Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol opioid-sparing effect in chronic pain
NCT03766269Phase 2Unknown
- Start
- Dec 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dronabinol in chronic pain. Primary endpoints: Pain Intensity Scale, Self-Reported Opioid Use (Opioid Dose) and 1 more. Status: unknown.
02
Drugs
dronabinol
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT03766269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03766269.